The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights
Sources FDA drug shortage: Food & Drug Administration (no date)
The injection form delivers medication directly into your subcutaneous tissue, bypassing stomach acid that would destroy oral GLP-1 compounds
It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction
It requires medical screening, realistic expectations, lifestyle support, side effect management, and long-term strategy
Analysis of FAERS data from 2004 to 2020 revealed significant associations between GLP-1 RA and various neoplasms, notably medullary thyroid cancer (PRR, 27.43), papillary thyroid cancer (PRR, 8.68), malignant pancreatic neoplasms (PRR, 9.86), and pancreatic neuroendocrine neoplasms (PRR, 2.86) [52]